scholarly journals The Proliferative Response to p27 Down-Regulation in Estrogen Plus Progestin Hormonal Therapy is Lost in Breast Tumors

2018 ◽  
Vol 11 (2) ◽  
pp. 518-527 ◽  
Author(s):  
Mark D. Aupperlee ◽  
Anastasia Kariagina ◽  
Nicole Zaremba ◽  
Marc D. Basson ◽  
Richard C. Schwartz ◽  
...  
Keyword(s):  
Hormonal Therapy ◽  
Proliferative Response ◽  
Breast Tumors ◽  
Down Regulation ◽  
Estrogen Plus Progestin

Effects of menopausal hormonal therapy on occult breast tumors

2013 ◽  
Vol 137 ◽  
pp. 150-156 ◽  
Author(s):  
Richard J. Santen ◽  
Yan Song ◽  
Wei Yue ◽  
Ji-Ping Wang ◽  
Daniel F. Heitjan
Keyword(s):  
Hormonal Therapy ◽  
Breast Tumors

Abstract 4605: Combinatory use of synthetic and natural ER beta modulators in treating hormonal-therapy-resistant breast tumors

2010 ◽  
Author(s):  
Manonmani Ganapathy ◽  
Hareesh Babu Bhaskaran Nair ◽  
Nameer Kirma ◽  
Naveen Krishnegowda ◽  
Ratna Vadlamudi ◽  
...  
Keyword(s):  
Hormonal Therapy ◽  
Breast Tumors

Up-regulation of human secreted frizzled homolog in apoptosis and its down-regulation in breast tumors

1998 ◽  
Vol 78 (1) ◽  
pp. 95-99 ◽  
Author(s):  
Zhongjun Zhou ◽  
Jianming Wang ◽  
Xiaoliang Han ◽  
Jiannian Zhou ◽  
Stig Linder
Keyword(s):  
Breast Tumors ◽  
Down Regulation

scholarly journals Treatment of benign hyperplasic processes of milk glands in patients with genital endometriosis

2021 ◽  
Vol 51 (4) ◽  
pp. 52-54
Author(s):  
A. B. Lliin ◽  
E. V. Malakhova
Keyword(s):  
Hormonal Therapy ◽  
Reproductive System ◽  
Breast Tumors ◽  
Health Condition ◽  
Simultaneous Development ◽  
Buserelin Treatment ◽  
Gonadotropic Hormones ◽  
Benign Breast Tumors

Health condition of 137 f emale with genital endometriosis before hormonal therapy and under the influence of antagonists ( danazol) and agonists of gonadotropic hormones (gozerelin, decapeptyl, buserelin) treatment was studied. Frequent association of genital endometriosis and benign breast tumors (91 % ) and e fficiency of using antagonists and agonists of gonadotropins in the occasions of the simultaneous development of hyperplasic processes in the reproductive system were revealed.

Primary hormonal therapy with exemestane in patients with breast tumors >3 cm in diameter: Results of a Spanish multicenter phase II trial

2004 ◽  
Vol 22 (14_suppl) ◽  
pp. 603-603 ◽  
Author(s):  
M. J. Gil Gil ◽  
A. Barnadas ◽  
L. Cirera ◽  
I. Tusquets ◽  
M. Muñoz ◽  
...  
Keyword(s):  
Phase Ii ◽  
Hormonal Therapy ◽  
Phase Ii Trial ◽  
Breast Tumors ◽  
Multicenter Phase

Primary hormonal therapy with exemestane in patients with breast tumors >3 cm in diameter: Results of a Spanish multicenter phase II trial

2004 ◽  
Vol 22 (14_suppl) ◽  
pp. 603-603 ◽  
Author(s):  
M. J. Gil Gil ◽  
A. Barnadas ◽  
L. Cirera ◽  
I. Tusquets ◽  
M. Muñoz ◽  
...  
Keyword(s):  
Phase Ii ◽  
Hormonal Therapy ◽  
Phase Ii Trial ◽  
Breast Tumors ◽  
Multicenter Phase

Abstract PD05-07: Use of Natural ER Beta Modulators in Treating Hormonal Therapy Resistant Breast Tumors

2010 ◽  
Author(s):  
M Ganapathy ◽  
NB Hareesh ◽  
NB Kirma ◽  
M Tagliaferri ◽  
I Cohen ◽  
...  
Keyword(s):  
Hormonal Therapy ◽  
Breast Tumors
Sign in / Sign up

Export Citation Format

Share Document